Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation

The important herbal pair for the treatment of COVID-19 and its possible mechanisms

(2021) Shujie Xia et al.   Chinese Medicine

An optimized BRD4 inhibitor effectively eliminates NF-κB-driven triple-negative breast cancer cells

(2021) Guan-Jun Yang et al.   BIOORGANIC CHEMISTRY

Innate immunity in diabetic kidney disease

(2020) Sydney C. W. Tang et al.   Nature Reviews Nephrology

Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis

(2020) Xia Mao et al.   PHARMACOLOGICAL RESEARCH

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats

(2020) Lei Zhang et al.   Scientific Reports

A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation

(2020) Yanqiong Zhang et al.   Molecular Therapy-Nucleic Acids

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

(2020) Sandra Rayego-Mateos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy

(2020) Guan-Jun Yang et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Tripterygium wilfordii : An inspiring resource for rheumatoid arthritis treatment

(2020) Yanqiong Zhang et al.   MEDICINAL RESEARCH REVIEWS

Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway

(2019) Huimin Yang et al.   Molecular Metabolism

Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model

(2019) Jung Yoon et al.   Nutrients

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

(2019) Hiddo J L Heerspink et al.   LANCET

CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease

(2018) Hans-Joachim Anders et al.   Nature Reviews Nephrology

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

(2018) Katherine R Tuttle et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Interleukin-18 and diabetic nephropathy: A review

(2018) Habib Yaribeygi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

ETCM: an encyclopaedia of traditional Chinese medicine

(2018) Hai-Yu Xu et al.   NUCLEIC ACIDS RESEARCH

Diabetic Nephropathy: From Pathophysiology to Treatment

(2017) Ziyan Shen et al.   Journal of Diabetes Research

Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy

(2017) Haoran Dai et al.   Journal of Diabetes Research

Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?

(2016) H. Gallagher et al.   DIABETES OBESITY & METABOLISM

Metadherin facilitates podocyte apoptosis in diabetic nephropathy

(2016) Wen-Ting Liu et al.   Cell Death & Disease

Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy

(2015) C. Hu et al.   CURRENT MEDICINAL CHEMISTRY

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

(2015) Dick de Zeeuw et al.   Lancet Diabetes & Endocrinology

Molecular mechanisms of diabetic kidney disease

(2014) Kimberly Reidy et al.   JOURNAL OF CLINICAL INVESTIGATION

Diabetic Nephropathy and Extracellular Matrix

(2012) S. O. Kolset et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Effect of Arctiin on Glomerular Filtration Barrier Damage in STZ-Induced Diabetic Nephropathy Rats

(2012) Song-Tao Ma et al.   PHYTOTHERAPY RESEARCH

Podocyte Detachment in Type 2 Diabetic Nephropathy

(2011) E. Jennifer Weil et al.   AMERICAN JOURNAL OF NEPHROLOGY